BEAM

Beam Therapeutics Inc.

Healthcare›Biotechnology|NASDAQ Global Select|US

Price

$24.66

Market Cap

$2.51B

Beta

2.17

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+120.01%

EPS Growth (YoY)+77.95%

Revenue CAGR 3Y+31.88%

P/E Ratio0.0

PEG Ratio—

FCF Yield-14.33%

Debt / Equity0.24

Interest Coverage-36.1x

No credit card required

Already have an account? Sign in to view the full analysis for BEAM.